Bliss GVS Pharma Limited (BOM:506197)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical and Healthcare	9.27B	8.10B	7.70B	7.52B	7.47B
Pharmaceutical and Healthcare Growth	14.50%	5.13%	2.48%	0.55%	29.50%
Total	9.27B	8.10B	7.70B	7.52B	7.47B
Total Growth	14.50%	5.13%	2.48%	0.55%	29.50%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	673.41M	530.18M	444.42M	391.62M	562.32M
India Growth	27.02%	19.30%	13.48%	-30.36%	-35.02%
Outside India	8.50B	7.49B	7.21B	7.08B	6.82B
Outside India Growth	13.50%	3.79%	1.86%	3.90%	41.39%
Total	9.17B	8.02B	7.66B	7.47B	7.38B
Total Growth	14.39%	4.69%	2.47%	1.29%	29.76%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 4, 2026

Data Sources Report a data error